Abstract
Purpose
Sacral nerve neuromodulation (SNM) is a safe and effective therapy for the management of fecal and/or urinary incontinence. The generators InterStim™ and InterStim™ II (Medtronic™) are non-rechargeable active implantable medical devices with a limited lifespan. The aims of this study were to assess the generators’ median lifespan for all indications and the long-term hospital costs of the therapy.
Methods
This was a retrospective monocentric study that included 215 patients aged over 18 years who were treated by SNM for fecal incontinence and/or urinary incontinence. Lifespan was considered as the amount of time between definitive implantation and observed battery depletion by the surgeon and was assessed by the Kaplan–Meier method. Costs were assessed according to the activity-based pricing of the French public health care system.
Results
The median observed lifetime of stimulators implanted in our center was 7.29 years and 5.9 years for InterStim™ and InterStim™ II, respectively. The difference observed between the two generations was statistically significant. The modelling of primary implantation and renewal costs allowed us to observe that the decrease in the lifetime of Interstim™ II is associated with an increase in hospital costs over time. The retrospective study design is one limitation and we did not take into consideration stimulation’s settings.
Conclusions
The InterStim™ II lifespan is shorter than the first-generation device. This is associated with an increase of the long-term hospital costs. Additional information about the new neuromodulator will be required to choose the most appropriate IPG for the patient while optimizing the costs.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Data availability
The authors confirm that the data supporting the findings of this study are available within the article and its supplementary materials.
References
Faucheron J-L, Chodez M, Boillot B (2012) Neuromodulation for fecal and urinary incontinence: Functional results in 57 consecutive patients from a single institution. Dis Colon Rectum 55(12):1278–1283. https://doi.org/10.1097/DCR.0b013e31826c7789
Matzel KE, Chartier-Kastler E, Knowles CH et al (2017) Sacral neuromodulation: Standardized electrode placement technique. Neuromodulation Technol Neural Interface 20(8):816–824. https://doi.org/10.1097/DCR.0b013e31826c7789. PMID: 23135587
Peeters K, Sahai A, De Ridder D, Van Der Aa F (2014) Long-term follow-up of sacral neuromodulation for lower urinary tract dysfunction. BJU Int 113(5):789–794. https://doi.org/10.1111/bju.12571. PMID: 24238278
Meurette G, Siproudhis L, Leroi A-M, Damon H, Urs Josef Keller D, Faucheron J-L (2021) Sacral neuromodulation with the InterStim™ system for faecal incontinence: Results from a prospective French multicentre observational study. Colorectal Dis Off J Assoc Coloproctology G B Irel 23(6):1463–1473. https://doi.org/10.1111/codi.15507. Epub 2021 Mar 12 PMID: 33387373
Desprez C, Damon H, Meurette G et al (2020) Ten-year evaluation of a large retrospective cohort treated by sacral nerve modulation for fecal incontinence: Results of a French multicenter study. Ann Surg. https://doi.org/10.1097/SLA.0000000000004251. PMID: 32740249
Duchalais E, Meurette G, Perrot B, Wyart V, Kubis C, Lehur P-A (2016) Exhausted implanted pulse generator in sacral nerve stimulation for faecal incontinence: What next in daily practice for patients? Int J Colorectal Dis 31(2):439–444. https://doi.org/10.1007/s00384-015-2433-1. Epub 2015 Nov 10 PMID: 26552785
Knowles CH, Wachter S, Engelberg S et al (2021) The science behind programming algorithms for sacral neuromodulation. Colorectal Dis 23:592–602. https://doi.org/10.1111/codi.15390. PMID: 33010084
Leroi AM, Damon H, Faucheron JL et al (2009) Sacral nerve stimulation in faecal incontinence: Position statement based on a collective experience. Colorectal Dis Off J Assoc Coloproctology G B Irel 11(6):572–583. https://doi.org/10.1111/j.1463-1318.2009.01914.x. PMID: 19508514
Widmann B, Galata C, Warschkow R et al (2019) Success and complication rates after sacral neuromodulation for fecal incontinence and constipation: A single-center follow-up study. J Neurogastroenterol Motil 25(1):159–170. https://doi.org/10.5056/jnm17106
Spinelli M, Sievert K-D (2008) Latest technologic and surgical developments in using InterStim therapy for sacral neuromodulation: Impact on treatment success and safety. Eur Urol 54(6):1287–1296. https://doi.org/10.1016/j.eururo.2008.01.076
Powell CR, Kreder KJ (2010) Long-term outcomes of urgency-frequency syndrome due to painful bladder syndrome treated with sacral neuromodulation and analysis of failures. J Urol 183(1):173–176. https://doi.org/10.1016/j.juro.2009.08.142. PMID: 19913835
Al-zahrani AA, Elzayat EA, Gajewski JB (2011) Long-term outcome and surgical interventions after sacral neuromodulation implant for lower urinary tract symptoms: 14-year experience at 1 center. J Urol 185(3):981–986. https://doi.org/10.1016/j.juro.2010.10.054. Epub 2011 Jan 19 PMID: 21247597
Leroi A-M, Lenne X, Dervaux B et al (2011) Outcome and cost analysis of sacral nerve modulation for treating urinary and/or fecal incontinence. Ann Surg 253(4):720–732. https://doi.org/10.1097/SLA.0b013e318210f1f4. PMID: 21475012
Altomare DF, Giannini I, Giuratrabocchetta S, Digennaro R (2013) The effects of sacral nerve stimulation on continence are temporarily maintained after turning the stimulator off. Colorectal Dis Off J Assoc Coloproctol G B Irel 15(12):e741–748. https://doi.org/10.1111/codi.12418. PMID: 24102954
Gallas S, Michot F, Faucheron JL et al (2011) Predictive factors for successful sacral nerve stimulation in the treatment of faecal incontinence: Results of trial stimulation in 200 patients. Colorectal Dis Off J Assoc Coloproctol G B Irel 13(6):689–696. https://doi.org/10.1111/j.1463-1318.2010.02260.x
Faucheron J-L, Voirin D, Badic B (2010) Sacral nerve stimulation for fecal incontinence: Causes of surgical revision from a series of 87 consecutive patients operated on in a single institution. Dis Colon Rectum 53(11):1501–1507. https://doi.org/10.1007/DCR.0b013e3181f1cf14. PMID: 20940598
Altomare DF, Giuratrabocchetta S, Knowles CH, Muñoz Duyos A, Robert-Yap J, Matzel KE (2015) Long-term outcomes of sacral nerve stimulation for faecal incontinence. Br J Surg 102(4):407–415. https://doi.org/10.1002/bjs.9740. Epub 2015 Feb 2 PMID: 25644687
Mege D, Meurette G, Brochard C et al (2019) Sacral nerve modulation for faecal incontinence: Influence of age on outcomes and complications. A multicentre study. Colorectal Dis Off J Assoc Coloproctology G B Irel 21(9):1058–1066. https://doi.org/10.1111/codi.14649
Funding
No funding was received for this study.
Author information
Authors and Affiliations
Contributions
Data acquisition: AD, DL, Drafting of manuscript: AD, FR, Critical revision: J-LF, CT, PB, FR, AD.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Daikh, A., Reymond, F., Lombardo, D. et al. Retrospective study of sacral neuromodulator implantations in a French hospital center: Lifespan and hospital costs assessment. Int J Colorectal Dis 38, 273 (2023). https://doi.org/10.1007/s00384-023-04569-5
Accepted:
Published:
DOI: https://doi.org/10.1007/s00384-023-04569-5